CN116531547A - 一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用 - Google Patents
一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用 Download PDFInfo
- Publication number
- CN116531547A CN116531547A CN202310302792.7A CN202310302792A CN116531547A CN 116531547 A CN116531547 A CN 116531547A CN 202310302792 A CN202310302792 A CN 202310302792A CN 116531547 A CN116531547 A CN 116531547A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- substrate according
- sanitary
- cedar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000474 nursing effect Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 230000008439 repair process Effects 0.000 title claims abstract description 16
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 15
- 239000000463 material Substances 0.000 title claims abstract description 14
- 241000218645 Cedrus Species 0.000 title claims abstract description 13
- 239000000419 plant extract Substances 0.000 title claims description 11
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 27
- 239000004530 micro-emulsion Substances 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 32
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 claims description 32
- 229940082500 cetostearyl alcohol Drugs 0.000 claims description 31
- 238000003756 stirring Methods 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 21
- 239000000758 substrate Substances 0.000 claims description 19
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 16
- 241000147041 Guaiacum officinale Species 0.000 claims description 16
- 241001673966 Magnolia officinalis Species 0.000 claims description 16
- 229940091561 guaiac Drugs 0.000 claims description 16
- 241000544656 Cedrus atlantica Species 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 claims description 14
- 244000163122 Curcuma domestica Species 0.000 claims description 14
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 14
- 235000003373 curcuma longa Nutrition 0.000 claims description 14
- 235000013976 turmeric Nutrition 0.000 claims description 14
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 14
- 241000736199 Paeonia Species 0.000 claims description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 13
- 239000000341 volatile oil Substances 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 229940064062 alpha-glucan oligosaccharide Drugs 0.000 claims description 11
- 239000002562 thickening agent Substances 0.000 claims description 10
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 claims description 9
- 239000004359 castor oil Substances 0.000 claims description 9
- 235000019438 castor oil Nutrition 0.000 claims description 9
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 9
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims description 9
- 239000003906 humectant Substances 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 231100000344 non-irritating Toxicity 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 9
- 230000002335 preservative effect Effects 0.000 claims description 9
- PBDAWQLIMPWEEF-JEDNCBNOSA-M sodium;(2s)-2,6-diaminohexanoate Chemical compound [Na+].NCCCC[C@H](N)C([O-])=O PBDAWQLIMPWEEF-JEDNCBNOSA-M 0.000 claims description 9
- 241000186660 Lactobacillus Species 0.000 claims description 8
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 claims description 8
- 229940039696 lactobacillus Drugs 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims description 7
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 7
- 229940074979 cetyl palmitate Drugs 0.000 claims description 7
- 238000007599 discharging Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000004745 nonwoven fabric Substances 0.000 claims description 7
- 229960005323 phenoxyethanol Drugs 0.000 claims description 7
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 7
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 7
- 229940068968 polysorbate 80 Drugs 0.000 claims description 7
- 229920000053 polysorbate 80 Polymers 0.000 claims description 7
- 229920000858 Cyclodextrin Polymers 0.000 claims description 6
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 6
- 229930182478 glucoside Natural products 0.000 claims description 6
- 150000008131 glucosides Chemical class 0.000 claims description 6
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 claims description 6
- 229920000570 polyether Polymers 0.000 claims description 6
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 6
- 229940059958 centella asiatica extract Drugs 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical group CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 239000000043 antiallergic agent Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000005507 spraying Methods 0.000 claims description 3
- 239000002344 surface layer Substances 0.000 claims description 3
- 229920000310 Alpha glucan Polymers 0.000 claims description 2
- 230000002421 anti-septic effect Effects 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims 3
- 206010070834 Sensitisation Diseases 0.000 claims 1
- 241000894006 Bacteria Species 0.000 abstract description 13
- 239000000047 product Substances 0.000 abstract description 11
- 208000003251 Pruritus Diseases 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 9
- 208000002193 Pain Diseases 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 6
- 230000004054 inflammatory process Effects 0.000 abstract description 6
- 230000007803 itching Effects 0.000 abstract description 6
- 238000000605 extraction Methods 0.000 abstract description 5
- 230000036407 pain Effects 0.000 abstract description 5
- 210000003905 vulva Anatomy 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000007794 irritation Effects 0.000 abstract description 3
- 239000012466 permeate Substances 0.000 abstract description 3
- 239000002245 particle Substances 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 26
- 230000000638 stimulation Effects 0.000 description 11
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 230000001681 protective effect Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical group OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 4
- 229940087068 glyceryl caprylate Drugs 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 3
- -1 diterpenoid compounds Chemical class 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229930004725 sesquiterpene Natural products 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- PAEMERHSTIDLSE-VEIQOZLZSA-N (3r,4s,5s,6r)-2-hexadecoxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound CCCCCCCCCCCCCCCCOC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O PAEMERHSTIDLSE-VEIQOZLZSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 240000006982 Guaiacum sanctum Species 0.000 description 2
- 235000004440 Guaiacum sanctum Nutrition 0.000 description 2
- FWKQNCXZGNBPFD-UHFFFAOYSA-N Guaiazulene Chemical compound CC(C)C1=CC=C(C)C2=CC=C(C)C2=C1 FWKQNCXZGNBPFD-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 206010056344 Menstrual discomfort Diseases 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000736262 Microbiota Species 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- IRAQOCYXUMOFCW-CXTNEJHOSA-N cedrene Chemical compound C1[C@]23[C@H](C)CC[C@H]3C(C)(C)[C@H]1C(C)=CC2 IRAQOCYXUMOFCW-CXTNEJHOSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- IRAQOCYXUMOFCW-UHFFFAOYSA-N di-epi-alpha-cedrene Natural products C1C23C(C)CCC3C(C)(C)C1C(C)=CC2 IRAQOCYXUMOFCW-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 229960002350 guaiazulen Drugs 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/626—Liposomes, micelles, vesicles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
本发明公开了一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用，抗敏修复精华液由以下原料制成：大西洋雪松精油、愈创木提取物、微乳功效乳化剂、牡丹籽油、厚朴提取物、α‑葡聚糖寡糖、乳酸菌姜黄发酵物、增稠剂、保湿剂、促进剂、抗敏剂、增溶剂和无刺激防腐组合物，本发明的各成分之间相互协同，制得的卫生巾（护垫、女性卫生裤）能够抑制细菌，明显降低女性阴部的刺激感和痛痒不适感，缓解阴部发炎、瘙痒、刺痛等症状，微乳功效乳化剂粒径细小、容易吸收，能将有效成份更好渗透到肌肤，可润养外阴皮肤，保持功效成分的活力，制得的卫生巾（护垫、女性卫生裤）不起丝、柔软舒适。
Description
技术领域
本发明涉及一种一次性卫生用品护理基材，特别是一种抗敏修复精华液一次性卫生用品护理基材、制备方法及应用。
背景技术
卫生巾、护垫和女性卫生裤产品贴近外阴皮肤，女性外阴处由于长时间处于潮湿闷热的环境，会引起外阴红肿、痛痒不适等感觉，而且化学物质的长时间接触易很容易被刺激而出现过敏，当细菌数量过多的时候，就很容易诱发炎症而产生不适，这些问题严重影响着女性的生活品质。
发明内容
为了克服现有技术的不足，本发明提供一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用。
本发明解决其技术问题所采用的技术方案是：
一种雪松植萃抗敏修复精华液一次性卫生用品护理基材，由以下重量份数的原料制成：大西洋雪松精油0.8-1.5份、愈创木提取物6.0-10.0份、微乳功效乳化剂2.0-5.0份、牡丹籽油5.0-10.0份、厚朴提取物1.0-2.0份、α-葡聚糖寡糖0.5-1.0份、乳酸菌姜黄发酵物0.5-1.5份、增稠剂0.05-0.2份、保湿剂5.0-10.0份、促进剂0.1-1.0份、抗敏剂0.1-1.0份、增溶剂1.0-5.0份、无刺激防腐组合物0.5-1.0份和纯水60-80份。
大西洋雪松精油物种来源：Cedrus atlantica英文名称：Atlas cedar/Cedarwood植物产地：摩洛哥提取部位：针叶细枝提取方式：蒸馏，从中分离出四种双萜类化合物，它们对革兰氏细菌有显著抗菌活性雪松烯和双萜醇成分有温和消炎抗菌的功效，能抑制皮肤上的细菌；再加上让人心神安定的倍半萜烯、倍半萜酮、倍半萜醇成分，可有效改善容易引起的精神因素（如压力），以及产后荷尔蒙急剧变化而出现的的身心问题，能释放身心压力、减轻焦虑，同时通过传递神经传导物质，能有效改善疼痛问题。
愈创木(GUAIACUM OFFICINALE)提取物（CAS:84650-13-5）有强烈的抗菌性，能促进皮肤排汗排毒，调节皮肤水油分泌，具有收敛皮肤，滋润调理的功效。
牡丹籽油具有极佳的护肤美容天然植物成分，可明显改善皮肤表皮细胞循环功能，抑制脂质过氧化作用的进行，改善新陈代谢，延缓皮肤衰老过程，有抗皱、保湿增白作用。牡丹籽油的渗透力很强，能迅速渗透到皮肤深层，强烈激活细胞潜能，整体改善肌肤状态，使肌肤得到再生修复。
厚朴提取物的主要有效成分是厚朴酚，厚朴酚为小分子量天然产物，其作用为先导成分，促进其他成分的吸收，厚朴提取物具有广谱的抗（抑）菌效果，对葡萄球菌、肺炎球菌、溶血性链球菌等革兰氏阳性菌及痢疾杆菌、伤寒杆菌、大肠杆菌、枯草杆菌等革兰氏阴性杆菌均有抗菌作用，对皮肤真菌亦有一定的抑制作用。厚朴提取物也具有良好的抗氧化功效，可以防止脂质过氧化，延缓衰老。厚朴提取物主要通过清除自由基(DPPH,OH-)、增强抗氧化酶活性、阻断脂质过氧化机理起到抗氧化作用。
α-葡聚糖寡糖（CAS：27707-45-5）是一种碳水化合物分子，具有生物选择性和水结合能力，通过鼓励有益细菌的生长来稳定皮肤的微生态，是一种强大的益生菌，有助于维持和支持皮肤的天然微生物群。
乳酸菌姜黄发酵物，主要成分为丁二醇、姜黄（CURCUMA LONGA）根提取物、乳酸杆菌发酵产物、1,2-己二醇，具有抗菌，抗炎，软化角质的作用，有很好的光滑嫩肤、保湿效果，能增进上皮细胞新陈代谢的速度，促使肌肤更新，抑制黑色素酶的活性，美白护肤。
所述微乳功效乳化剂为由以下重量份数的原料制成：丁二醇（CAS：107-88-0）10-15份、氢化蓖麻油10-15份、氢化聚异丁烯(CAS：61693-08-1) 1-3份、鲸蜡硬脂醇异壬酸酯（CAS：84878-33-1）1-3份、鲸蜡硬脂醇聚醚-20（CAS：68439-49-6）1-3份、鲸蜡硬脂醇（CAS:67762-27-0）1-3份、甘油硬脂酸酯（CAS:123-94-4）1-3份、鲸蜡醇棕榈酸酯（CAS：540-10-3）1-3份、二赖氨酸钠15-20份、苯氧乙醇1-3份和纯水60-70份。
所述增稠剂为鲸蜡硬脂基葡糖苷（CAS:246159-33-1）和鲸蜡硬脂醇（化学式：C34H72O2）任意比例的混合物。
所述无刺激防腐组合物为相同比例的甘油辛酸酯、辛酰羟肟酸（化学式是C8H17NO2）、对羟基苯乙酮（分子式C8H8O2）和丁二醇（化学式为C4H10O2）的混合物，采用的原料均为温和型原料，对皮肤无刺激，且上述无刺激防腐组合物能赋予本发明优异的防腐性能，延长产品的保存时间。
所述抗敏剂为积雪草提取物和环糊精（分子式为C42H70O35）任意比例的混合物，能有效缓解女性阴部的刺激感和痛痒不适感，缓解阴部发炎、阴部瘙痒、刺痛等症状。
所述增溶剂为聚山梨酯-80（化学式是C64H124O26），聚山梨酯-80是一类优良的O/W型乳化剂，高浓度电解质和pH值的改变对其乳化能力影响很小。对植物油、矿物油、动物油脂等均有良好的乳化作用，对非极性化合物和含极性集团的化合物均有良好的增溶效果。
所述保湿剂为丁二醇（化学式为C4H10O2），丁二醇是一种亲水性的润肤物质，在较低湿度范围内具有结合水的能力，给皮肤补充水分，它们可以通过控制产品与周围空气之间水分的交换使皮肤维持在高于正常水含量的平衡状态，起到减轻皮肤干燥的作用。
本发明的促进剂为愈创薁纳米脂质体，愈创薁（Guaiazulene GYZ）具有强大的消炎和抗菌作用，能够防止细菌感染促进伤口愈合，抗过敏、去红斑，此外还有抗氧化活性有效延缓皮肤衰老。
本发明的微乳功效乳化剂中，鲸蜡硬脂醇异壬酸酯作为作柔润剂使用，可以增加肌肤的柔润性，肤质细腻光滑，鲸蜡硬脂醇聚醚-20作为清洁剂、乳化剂、表面活性剂使用，鲸蜡硬脂醇是非离子乳化剂,可以增稠水性配方，具有一定的保湿作用，鲸蜡醇棕榈酸酯能够起到护肤美白、保湿作用。
一种制备上述护理基材的方法，其步骤如下：
（1）、组分A的制备：将上述重量份数的大西洋雪松精油、愈创木提取物、微乳功效乳化剂、牡丹籽油、厚朴提取物、α-葡聚糖寡糖、乳酸菌姜黄发酵物加入搅拌机A中，然后在转速为50-60转/分下混合5-10分钟，制得组分A。
（2）、组分B的制备：将上述重量份数的保湿剂、促进剂、抗敏剂、增溶剂和无刺激防腐组合物加入搅拌机B中，然后在转速为50-60转/分下混合5-10分钟，制得组分B。
（3）、混合出料：将上述重量份数的纯水加入主搅拌釜中，接着将组分A加入主搅拌釜中，保持转速在50-60转/分搅拌15-25分钟，边搅拌边加热主搅拌釜至45℃，然后将组分B在45℃下加入主搅拌釜中，保持转速在50-60转/分,搅拌5-10分钟，最后将上述重量份数的增稠剂加入主搅拌釜中，保持转速在50-60转/分,搅拌15-25分钟，静置，出料。
一种应用上述护理基材的卫生巾（护垫、女性卫生裤），制备工艺如下：将所述雪松植萃抗敏修复精华液一次性卫生用品护理基材喷涂于卫生巾（护垫、女性卫生裤）表层的无纺布，然后对所述无纺布进行滚轮挤压，再进行烘干，烘干温度为80-85℃，干燥后即得雪松植萃抗敏修复精华液卫生巾（护垫、女性卫生裤）。
本发明的有益效果是：本发明的卫生巾（护垫、女性卫生裤）添加了大西洋雪松精油、愈创木提取物、微乳功效乳化剂、牡丹籽油、厚朴提取物、α-葡聚糖寡糖、乳酸菌姜黄发酵物、增稠剂、保湿剂、促进剂、抗敏剂、增溶剂和无刺激防腐组合物，各成分之间相互协同，制得的卫生巾（护垫、女性卫生裤）能够抑制细菌，明显降低女性阴部的刺激感和痛痒不适感，缓解阴部发炎、阴部瘙痒、刺痛等症状。
本发明的制备方法包括组分A和B的制备以及混合出料，其中，微乳功效乳化剂粒径细小、容易吸收，能将有效成份更好渗透到肌肤，可润养外阴皮肤，保持功效成分的活力。
实施方式
在本发明所有实施例中，关于温度和压力没有特别强调的，均为常温常压，关于设备使用没有特别说明的，均按常规设置来使用即可。
实施例
护理基材组分：大西洋雪松精油（广州纳农进出口有限责任公司，品名：YS大西洋雪松精油，以下实施例相同）0.8份、愈创木提取物（深圳市瑞吉特生物科技有限公司生产，以下实施例相同）6.0、微乳功效乳化剂2.0份、牡丹籽油（广州雍和生物科技有限公司生产，以下实施例相同）5.0份、厚朴提取物（罗德医药公司生产，产品名：RODE-厚朴提取物，以下实施例相同）1.0份、α-葡聚糖寡糖（浦瑞生物医药生产，产品名称：PuriActives®α-葡聚糖寡糖，以下实施例相同）0.5份、乳酸菌姜黄发酵物（容海生物生产，产品名称：Turmericgel姜黄凝胶）0.5份、鲸蜡硬脂基葡糖苷（增稠剂）0.01份、鲸蜡硬脂醇（增稠剂）0.04份、丁二醇（保湿剂）5.0份、愈创薁纳米脂质体（促进剂，浦瑞生物医药技术有限公司生产，品名：愈创薁纳米脂质体（Nano-Liposomal Guaiazulene），以下实施例相同）0.1份、积雪草提取物（抗敏剂，山阳联峰生物科技有限责任公司生产的积雪草提取物，以下实施例相同）0.05份，环糊精（抗敏剂，分子式为C42H70O35）0.05份、聚山梨酯-80（增溶剂，化学式是C64H124O26）1.0份，甘油辛酸酯（无刺激防腐组合物）0.125份、辛酰羟肟酸（无刺激防腐组合物）0.125份、对羟基苯乙酮（无刺激防腐组合物）0.125份、丁二醇0.125份、纯水60份。
微乳功效乳化剂组分：丁二醇（CAS：107-88-0）10份、氢化蓖麻油（优选湖北东曹化学科技有限公司生产的PEG-60氢化蓖麻油，以下实施例相同）10份、氢化聚异丁烯(CAS：61693-08-1，优选湖北鑫润德化工有限公司生产的，以下实施例相同) 1份、鲸蜡硬脂醇异壬酸酯（CAS：84878-33-1）1份、鲸蜡硬脂醇聚醚-20（CAS：68439-49-6）1份、鲸蜡硬脂醇（CAS:67762-27-0）1份、甘油硬脂酸酯（CAS:123-94-4）1份、鲸蜡醇棕榈酸酯（CAS：540-10-3）1份、二赖氨酸钠（又名二(月桂酰胺谷氨酰胺)赖氨酸钠，选用广州承皓贸易有限公司生产）15份、苯氧乙醇1份和纯水（去离子水、纯水、蒸馏水和纯水中的任意一种）60份。
所述微乳功效乳化剂的制备工艺为：预热反应釜，将反应釜升温至50-60℃（在此范围内均可，没有严格要求），加入上述重量份数的氢化蓖麻油、氢化聚异丁烯、鲸蜡硬脂醇异壬酸酯、鲸蜡硬脂醇聚醚-20、鲸蜡硬脂醇、甘油硬脂酸酯和鲸蜡醇棕榈酸酯，搅拌15-20min（在此范围内均可，没有严格要求），搅拌速度为60-65r/min（在此范围内均可，没有严格要求），制得油相；搅拌完后倒入上述重量份数的丁二醇、二赖氨酸钠和纯水，继续反应20-25min（在此范围内均可，没有严格要求），保持60-65 r/min（在此范围内均可，没有严格要求）的搅拌速度和50-60℃（在此范围内均可，没有严格要求）的反应温度，然后冷却至室温，静置，得微乳功效乳化剂。
一种制备上述雪松植萃抗敏修复精华液一次性卫生用品护理基材的方法，其步骤如下：
（1）、组分A的制备：将上述重量份数的大西洋雪松精油、愈创木提取物、微乳功效乳化剂、牡丹籽油、厚朴提取物、α-葡聚糖寡糖、乳酸菌姜黄发酵物加入搅拌机A中，然后在转速为50-60转/分（在此范围内均可，没有严格要求）下混合5-10分钟（在此范围内均可，没有严格要求），制得组分A。
（2）、组分B的制备：将上述重量份数的保湿剂、促进剂、抗敏剂、增溶剂和无刺激防腐组合物加入搅拌机B中，然后在转速为50-60转/分（在此范围内均可，没有严格要求）下混合5-10分钟（在此范围内均可，没有严格要求），制得组分B。
（3）、混合出料：将上述重量份数的纯水加入主搅拌釜中，接着将组分A加入主搅拌釜中，保持转速在50-60转/分（在此范围内均可，没有严格要求）搅拌15-25分钟（在此范围内均可，没有严格要求），边搅拌边加热主搅拌釜至45℃，然后将组分B在45℃下加入主搅拌釜中，保持转速在50-60转/分（在此范围内均可，没有严格要求）,搅拌5-10分钟，最后将上述重量份数的增稠剂加入主搅拌釜中，保持转速在50-60转/分（在此范围内均可，没有严格要求）,搅拌15-25分钟（在此范围内均可，没有严格要求），静置，出料。
一种应用上述护理基材的卫生巾（护垫、女性卫生裤），制备工艺如下：将所述雪松植萃抗敏修复精华液一次性卫生用品护理基材喷涂于卫生巾（护垫、女性卫生裤）表层的无纺布，然后对所述无纺布进行滚轮挤压，再进行烘干，烘干温度为80-85℃（在此范围内均可，没有严格要求），干燥后即得雪松植萃抗敏修复精华液卫生巾（护垫、女性卫生裤）。
以下的实施例中，只是组分不同，微乳功效乳化剂的制备工艺、护理基材的制备工艺、卫生巾（护垫、女性卫生裤）的制备工艺均与实施例1相同。
实施例
护理基材组分：大西洋雪松精油1.0份、愈创木提取物7.0、微乳功效乳化剂3.0份、牡丹籽油5.0份、厚朴提取物1.5份、α-葡聚糖寡糖0.6份、乳酸菌姜黄发酵物0.8份、鲸蜡硬脂基葡糖苷0.5份、鲸蜡硬脂醇0.5份、丁二醇6.0份、愈创薁纳米脂质体0.3份、积雪草提取物0.1份，环糊精0.1份、聚山梨酯-80 2.0份，甘油辛酸酯0.15份、辛酰羟肟酸0.15份、对羟基苯乙酮 0.15份、丁二醇0.15份、纯水65份。
微乳功效乳化剂组分：丁二醇12份、氢化蓖麻油10份、氢化聚异丁烯2份、鲸蜡硬脂醇异壬酸酯2份、鲸蜡硬脂醇聚醚-20 2份、鲸蜡硬脂醇1份、甘油硬脂酸酯2份、鲸蜡醇棕榈酸酯1份、二赖氨酸钠15份、苯氧乙醇1份和纯水65份。
实施例
护理基材组分：大西洋雪松精油1.2份、愈创木提取物8.0、微乳功效乳化剂3.5份、牡丹籽油8.0份、厚朴提取物1.0份、α-葡聚糖寡糖0.7份、乳酸菌姜黄发酵物1.0份、鲸蜡硬脂基葡糖苷0.1份、鲸蜡硬脂醇0.05份、丁二醇8.0份、愈创薁纳米脂质体0.6份、积雪草提取物0.1份，环糊精0.2份、聚山梨酯-80 3.0份，甘油辛酸酯0.2份、辛酰羟肟酸0.2份、对羟基苯乙酮 0.2份、丁二醇0.2份、纯水70份。
微乳功效乳化剂组分：丁二醇13份、氢化蓖麻油12份、氢化聚异丁烯1.5份、鲸蜡硬脂醇异壬酸酯1份、鲸蜡硬脂醇聚醚-20 3份、鲸蜡硬脂醇2份、甘油硬脂酸酯2份、鲸蜡醇棕榈酸酯2份、二赖氨酸钠18份、苯氧乙醇2份和纯水65份。
实施例
护理基材组分：大西洋雪松精油1.5份、愈创木提取物9.0、微乳功效乳化剂4.0份、牡丹籽油9.0份、厚朴提取物2.0份、α-葡聚糖寡糖0.8份、乳酸菌姜黄发酵物1.3份、鲸蜡硬脂基葡糖苷0.1份、鲸蜡硬脂醇0.1份、丁二醇9.0份、愈创薁纳米脂质体0.8份、积雪草提取物0.5份，环糊精0.3份、聚山梨酯-80 4.0份，甘油辛酸酯0.2份、辛酰羟肟酸0.2份、对羟基苯乙酮 0.2份、丁二醇0.2份、纯水75份。
微乳功效乳化剂组分：丁二醇15份、氢化蓖麻油12份、氢化聚异丁烯2份、鲸蜡硬脂醇异壬酸酯1份、鲸蜡硬脂醇聚醚-20 3份、鲸蜡硬脂醇3份、甘油硬脂酸酯3份、鲸蜡醇棕榈酸酯2份、二赖氨酸钠20份、苯氧乙醇2份和纯水70份。
实施例
护理基材组分：大西洋雪松精油1.5份、愈创木提取物10.0、微乳功效乳化剂5.0份、牡丹籽油10.0份、厚朴提取物2.0份、α-葡聚糖寡糖1.0份、乳酸菌姜黄发酵物1.5份、鲸蜡硬脂基葡糖苷0.1份、鲸蜡硬脂醇0.1份、丁二醇10.0份、愈创薁纳米脂质体1.0份、积雪草提取物0.5份，环糊精0.5份、聚山梨酯-80 5.0份，甘油辛酸酯0.25份、辛酰羟肟酸0.25份、对羟基苯乙酮 0.25份、丁二醇0.25份、纯水80份。
微乳功效乳化剂组分：丁二醇15份、氢化蓖麻油15份、氢化聚异丁烯3份、鲸蜡硬脂醇异壬酸酯3份、鲸蜡硬脂醇聚醚-20 2份、鲸蜡硬脂醇3份、甘油硬脂酸酯3份、鲸蜡醇棕榈酸酯3份、二赖氨酸钠20份、苯氧乙醇3份和纯水70份。
志愿者实际使用测试：于某医院妇科门诊招募志愿者，所招募志愿者条件为：具有阴部敏感体质，共招募女性志愿者100人，随机分成2组，每组50人，分别为测试组1、测试组2，测试组1使用实施例1-5制成的卫生巾，测试组2使用国外品牌某抗菌卫生巾（护垫）和卫生裤，样品数量按三个月的生理期计。
本次测试所使用卫生巾（护垫）和卫生裤均已撕去商标等标志性物质，志愿者并不知道自己所使用为何种卫生巾（护垫）和卫生裤，志愿者需在月经结束后向实验人员提供自己的使用感受。使用感受包括：阴部是否清爽、阴道是否痛痒、白带是否减少，是否减缓经期不适感、是否与卫生有摩擦感体验进行评分，每项满分10分，感觉越好评分越高，计算各组志愿者三个月经期三次平均分。
测试结果表明：使用实施例1-5的卫生巾（护垫）和卫生裤的测试组1在阴部清爽、减缓瘙痒、减缓经期不适感、减少与卫生有摩擦感等方面明显优于测试组2。由此可得应用愈创木植萃修复精华液制得的卫生巾（护垫）和卫生裤护理基材制得的卫生巾（护垫）在使用时营养成分被外阴皮肤吸收，能增强皮肤细胞活力和缓解阴部发炎等症状，用后触感有丝滑且达到滋养肌肤、皮肤的微生态平衡的目的。
在本说明书的描述中,术语“一个实施例”、“一些实施例”、“具体实施例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施例或实例。而且,描述的具体特征、结构、材料或特点可以在任何的一个或多个实施例或示例中以合适的方式结合。
尽管已经示出和描述了本发明的实施例,本领域的普通技术人员可以理解，在不脱离本发明的原理和宗旨的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由权利要求及其等同物限定。
Claims (10)
1.一种雪松植萃抗敏修复精华液一次性卫生用品护理基材，其特征在于由以下重量份数的原料制成：大西洋雪松精油0.8-1.5份、愈创木提取物6.0-10.0份、微乳功效乳化剂2.0-5.0份、牡丹籽油5.0-10.0份、厚朴提取物1.0-2.0份、α-葡聚糖寡糖0.5-1.0份、乳酸菌姜黄发酵物0.5-1.5份、增稠剂0.05-0.2份、保湿剂5.0-10.0份、促进剂0.1-1.0份、抗敏剂0.1-1.0份、增溶剂1.0-5.0份、无刺激防腐组合物0.5-1.0份和纯水60-80份。
2.根据权利要求1所述的护理基材，其特征在于所述微乳功效乳化剂为由以下重量份数的原料制成：丁二醇10-15份、氢化蓖麻油10-15份、氢化聚异丁烯1-3份、鲸蜡硬脂醇异壬酸酯1-3份、鲸蜡硬脂醇聚醚-20 1-3份、鲸蜡硬脂醇1-3份、甘油硬脂酸酯1-3份、鲸蜡醇棕榈酸酯1-3份、二赖氨酸钠15-20份、苯氧乙醇1-3份和纯水60-70份。
3.根据权利要求1所述的护理基材，其特征在于所述增稠剂为鲸蜡硬脂基葡糖苷和鲸蜡硬脂醇任意比例的混合物。
4.根据权利要求1所述的护理基材，其特征在于所述保湿剂为丁二醇。
5.根据权利要求1所述的护理基材，其特征在于所述促进剂为愈创薁纳米脂质体。
6.根据权利要求1所述的护理基材，其特征在于所述抗敏剂为积雪草提取物和环糊精任意比例的混合物。
7.根据权利要求1所述的护理基材，其特征在于所述增溶剂为聚山梨酯-80。
8.根据权利要求1所述的护理基材，其特征在于所述无刺激防腐组合物为相同比例的甘油辛酸酯、辛酰羟肟酸、对羟基苯乙酮和丁二醇的混合物。
9.一种制备如权利要求1-8任一所述护理基材的方法，其特征在于步骤如下：
（1）、组分A的制备：将上述重量份数的大西洋雪松精油、愈创木提取物、微乳功效乳化剂、牡丹籽油、厚朴提取物、α-葡聚糖寡糖、乳酸菌姜黄发酵物加入搅拌机A中，然后在转速为50-60转/分下混合5-10分钟，制得组分A；
（2）、组分B的制备：将上述重量份数的保湿剂、促进剂、抗敏剂、增溶剂和无刺激防腐组合物加入搅拌机B中，然后在转速为50-60转/分下混合5-10分钟，制得组分B；
（3）、混合出料：将上述重量份数的纯水加入主搅拌釜中，接着将组分A加入主搅拌釜中，保持转速在50-60转/分搅拌15-25分钟，边搅拌边加热主搅拌釜至45℃，然后将组分B在45℃下加入主搅拌釜中，保持转速在50-60转/分,搅拌5-10分钟，最后将上述重量份数的增稠剂加入主搅拌釜中，保持转速在50-60转/分,搅拌15-25分钟，静置，出料。
10.一种应用如权利要求1-8任一所述护理基材的卫生巾，其特征在于制备工艺如下：将所述雪松植萃抗敏修复精华液一次性卫生用品护理基材喷涂于表层的无纺布，然后对所述无纺布进行滚轮挤压，再进行烘干，烘干温度为80-85℃，干燥后即得雪松植萃抗敏修复精华液卫生巾。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310302792.7A CN116531547B (zh) | 2023-03-27 | 一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310302792.7A CN116531547B (zh) | 2023-03-27 | 一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116531547A true CN116531547A (zh) | 2023-08-04 |
| CN116531547B CN116531547B (zh) | 2024-07-12 |
Family
ID=
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117598923A (zh) * | 2023-11-30 | 2024-02-27 | 名宇(广东)化妆品科技有限公司 | 一种抗皱紧致组合物及制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR049394A1 (es) * | 2004-06-28 | 2006-07-26 | Grupo P I Mabe Sa De C V | Mezcla de aceites esenciales en articulos absorbentes desechables y dichos articulos |
| EP2915547A1 (en) * | 2014-03-03 | 2015-09-09 | Ontex BVBA | Hygiene article comprising an effective odour control system |
| CN111714679A (zh) * | 2020-06-18 | 2020-09-29 | 广东景兴健康护理实业股份有限公司 | 丝素蛋白美肌卫生巾或护垫护理基材的制备方法及其应用 |
| CN113209185A (zh) * | 2021-05-18 | 2021-08-06 | 江西中医药大学 | 一种广谱抗病毒中药挥发油制剂及其应用 |
| CN114652884A (zh) * | 2022-03-24 | 2022-06-24 | 广东景兴健康护理实业股份有限公司 | 一种山茶花舒缓精华液一次性卫生用品护理基材、制备方法及应用 |
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR049394A1 (es) * | 2004-06-28 | 2006-07-26 | Grupo P I Mabe Sa De C V | Mezcla de aceites esenciales en articulos absorbentes desechables y dichos articulos |
| EP2915547A1 (en) * | 2014-03-03 | 2015-09-09 | Ontex BVBA | Hygiene article comprising an effective odour control system |
| CN111714679A (zh) * | 2020-06-18 | 2020-09-29 | 广东景兴健康护理实业股份有限公司 | 丝素蛋白美肌卫生巾或护垫护理基材的制备方法及其应用 |
| CN113209185A (zh) * | 2021-05-18 | 2021-08-06 | 江西中医药大学 | 一种广谱抗病毒中药挥发油制剂及其应用 |
| CN114652884A (zh) * | 2022-03-24 | 2022-06-24 | 广东景兴健康护理实业股份有限公司 | 一种山茶花舒缓精华液一次性卫生用品护理基材、制备方法及应用 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117598923A (zh) * | 2023-11-30 | 2024-02-27 | 名宇(广东)化妆品科技有限公司 | 一种抗皱紧致组合物及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109044915B (zh) | 一种婴幼儿护臀膏及其制备工艺 | |
| CA2287451C (en) | Topical use of probiotic bacillus spores to prevent or control microbial infections | |
| CA2800382C (en) | Tamarind seed polysaccharide for use in the treatment of microbial infections | |
| CN110638727B (zh) | 一种婴幼儿护臀组合物及其制备方法和应用 | |
| CN112245347A (zh) | 一种防治尿布疹的护臀组合物及其制备方法 | |
| CN111759885A (zh) | 一种苦参组合物、苦参凝胶及其制备方法 | |
| KR102069297B1 (ko) | 여성 청결제 조성물 | |
| CN108815100A (zh) | 含有艾叶干细胞提取物的抑菌止痒护肤品及其制备方法 | |
| CN114652884B (zh) | 一种山茶花舒缓精华液一次性卫生用品护理基材、制备方法及应用 | |
| CN116531547B (zh) | 一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用 | |
| KR102115668B1 (ko) | 프로바이오틱스 발효물을 포함하는 항여드름 활성을 갖는 화장료 조성물 | |
| CN109847019B (zh) | 一种用于卫生用品的抑菌组合物及其制备方法 | |
| KR20210090870A (ko) | 마이크로바이옴을 이용한 피부 장벽 개선 효과가 우수한 화장료 조성물 | |
| KR20210072966A (ko) | 나노캡슐화된 센텔라 추출물과 칼라민을 포함하는 피부보습 또는 피부염증 개선용 나노캡슐 조성물 | |
| KR102675013B1 (ko) | 헴프씨드 추출물 및 헴프씨드 오일을 포함하는 여드름피부 개선용 조성물 | |
| CN111714679B (zh) | 丝素蛋白美肌卫生巾或护垫护理基材的制备方法及其应用 | |
| CN116531547A (zh) | 一种雪松植萃抗敏修复精华液一次性卫生用品护理基材、制备方法及应用 | |
| CN116585519A (zh) | 一种桃叶植萃舒缓修复精华液一次性卫生用品护理基材、制备方法及应用 | |
| CN111870590A (zh) | 液体祛痘贴及其制备方法 | |
| KR102413425B1 (ko) | 베타글루칸을 포함하는 여성 청결제용 조성물 및 이를 포함하는 진공 충진 앰플 | |
| KR101363028B1 (ko) | 레몬밤, 베르가못, 박하잎, 한련초 및 지구자 추출물을 유효성분으로 함유하는 여드름 예방, 개선 또는 치료용 화장용 조성물 | |
| CN117860649A (zh) | 一种调节皮肤微生态和修复肌肤屏障的组合物及应用 | |
| AU2022207164A1 (en) | Cosmetic method and composition based on short-chain fructooligosaccharides and a native starch | |
| KR20230115430A (ko) | 병아리콩물을 포함하는 항균 및 피부 보습용 조성물 및 이를 포함하는 피부용 팩 | |
| CN112807372A (zh) | 一种可治疗冻疮及皮肤干裂的乳膏 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant |